Possibly.
Percutaneous balloon coronary angioplasty is a therapeutic measure to unclog the blood vessels, but it is not permanent and patients are at risk of restenosis.
According to previous clinical observations, percutaneous balloon coronary angioplasty increases activity tolerance and improves the quality of patient’s survival compared to medical conservative therapy, but restenosis and thrombus formation still greatly affect its efficacy. As a result, the incidence of myocardial infarction and mortality are not significantly different from conservative treatment.
In recent years, the efficacy of coronary interventions has been improved by new antiplatelet agents. Patients should take a full course of antiplatelet drugs (e.g. aspirin, clopidogrel, etc.) as prescribed by the doctor. They should also improve their diet and lifestyle habits, eat a low-salt and low-fat diet, and exercise appropriately to reduce stress. Pharmacological treatment and lifestyle management should be coordinated to avoid restenosis and recurrence of cardiovascular events.